Discovered in 1976, Ebola is rare, deadly and has multiple variations. There is a vaccine for the Zaire type, now trials for another are underway.

Discovered in 1976, Ebola is rare, deadly and has multiple variants. There is a vaccine for the Zaire type. Now, trials for another strain are underway.

Ebola Virus: Origin, Transmission, And Impact 10 Years After Outbreak More than three quarters of those deaths occurred during a brutal outbreak in West Africa which began a decade ago.

A new study suggests the antiviral drug obeldesivir may be effective in curing Ebola Sudan infections, for which there are currently no approved vaccines or treatments.

It protects only against Zaire ebolavirus, not the other strains that can infect humans. The Ervebo vaccine does not contain the Ebola virus.

Three candidate vaccines in development for the Ebola Zaire strain were sent to Uganda, with the first arriving on December 8, to be evaluated in a clinical trial being run by the Makerere ...

Two vaccines against the Zaire strain of Ebola virus are immunogenic and safe in both adults and children, according to initial results from two phase II clinical trials published in the New ...

Researchers perform two randomized controlled trials to determine immunogenicity and safety of three Ebola vaccines.

Questions remain concerning the rapidity of immune responses and the durability and safety of vaccines used to prevent Zaire Ebola virus disease. We conducted two randomized, placebo-controlled tri ...

Infectious Disease > Ebola Zaire Ebola Vaccines Produce Antibody Responses as Early as 14 Days — Responses in adults and kids were maintained for 12 months for all three regimens by Ingrid Hein ...